Dendrite's Shareholders Approve Acquisition by Cegedim
May 04 2007 - 3:27PM
Business Wire
Dendrite International, Inc. (NASDAQ: DRTE) announced today that,
at a special meeting held in Bedminster,�NJ, Dendrite�s
shareholders approved its acquisition by French company, Cegedim SA
("Cegedim"). Subject to satisfaction of certain regulatory
approvals and other customary closing conditions, Dendrite expects
the transaction to be completed on or about May 9, 2007. On March
2, 2007, Dendrite announced that it had entered into an agreement
to be acquired by Cegedim in a merger transaction. Cegedim has
agreed to pay $16.00 in cash for each outstanding common share of
Dendrite upon the closing of the merger. About Dendrite Founded in
1986, Dendrite International enables sales, marketing, clinical and
compliance solutions for the global pharmaceutical industry. The
Company's clients are located in more than 50 countries and include
the world's top 20 pharmaceutical companies. For more information,
please visit http://www.dendrite.com. Note: Dendrite is a
registered trademark of Dendrite International, Inc. Forward
Looking Statements This press release contains certain statements
that are �forward-looking statements� within the meaning of Section
27A of the Securities Act of 1933 and Section 21E of the Securities
Exchange Act of 1934, as amended. Such statements are qualified by
the inherent risks and uncertainties surrounding future
expectations generally, and also may materially differ from actual
future experience involving any one or more of such statements.
Such risks and uncertainties include: Dendrite�s inability to
satisfy the conditions to closing the merger and other risk factors
as set forth from time to time in Dendrite�s filings with the SEC.
The inclusion of a forward-looking statement herein should not be
regarded as a representation by Dendrite that Dendrite�s objectives
will be achieved. Dendrite undertakes no obligation to publicly
update forward-looking statements, whether as a result of new
information, future events or otherwise.
Dendrite (NASDAQ:DRTE)
Historical Stock Chart
From Jul 2024 to Aug 2024
Dendrite (NASDAQ:DRTE)
Historical Stock Chart
From Aug 2023 to Aug 2024